Domestic pharmaceutical industry have been in critical phase for survival

Pharmaceutical business sources say that a series of the government drug-related policies designed to unilaterally reduce the reimbursement prices, such as drug price re-evaluation system and ex post facto drug management system, has hit severe blows to the domestic pharmaceutical industry.

There are mounting discontent at some quarters that the Korea Pharmaceutical Manufacturers Associati...